Rapamycin + peptides — rapa isn't a peptide but it keeps coming up
35 posts
Rapamycin (sirolimus) is the pharma longevity compound that actually has rodent data behind it. It's not a peptide. But every longevity peptide conversation eventually drags it in. Anyone running rapa alongside their peptide protocols, and how do you think about the stack?
5 Replies
117 posts
6-7 mg weekly pulsatile is the common protocol. Works via mTOR inhibition. No interaction of note with MOTS-c or Epithalon that I'm aware of. The stack is conceptually clean.
38 posts
Running rapa 6mg weekly alongside Epi 10/80 for the last 8 months. Feel neutral-to-fine. Blood glucose is very slightly higher during the 48h post-dose window which matches the literature.
39 posts
rapa is the one compound in this whole space that actually has me a little worried honestly, not in a "it's dangerous" way but more like I don't want to be that guy who's been running it for 3 years and finds out it tanks something at 10 years. The rodent data is legit but also rodents aren't us and they don't live long enough to catch delayed sides. That said yeah stacking it with peptides makes sense since they're hitting different pathways, just the rapa is gonna do like 80% of the theoretical work here. The peptides are nice but if you're doing one or the other, rapa wins on evidence every single time.
36 posts
Yeah but nobody running this stuff is actually doing proper baselines or follow-ups. Like how many people actually have comprehensive metabolic panels from before they started, then quarterly after, then cross-reference that against their lifestyle changes (sleep, diet, training). Rapa might be moving the needle but if you're also sleeping better or changed your eating, you have no idea what's doing the work. The rodent data is tight because they control for literally everything else. Real life you're a confounding variable soup.